4-phenylbutan-2-amine structure
|
Common Name | 4-phenylbutan-2-amine | ||
|---|---|---|---|---|
| CAS Number | 22374-89-6 | Molecular Weight | 149.233 | |
| Density | 0.9±0.1 g/cm3 | Boiling Point | 221.5±0.0 °C at 760 mmHg | |
| Molecular Formula | C10H15N | Melting Point | -50ºC | |
| MSDS | Chinese USA | Flash Point | 97.8±0.0 °C | |
| Symbol |
GHS05 |
Signal Word | Danger | |
| Name | 4-phenylbutan-2-amine |
|---|---|
| Synonym | More Synonyms |
| Density | 0.9±0.1 g/cm3 |
|---|---|
| Boiling Point | 221.5±0.0 °C at 760 mmHg |
| Melting Point | -50ºC |
| Molecular Formula | C10H15N |
| Molecular Weight | 149.233 |
| Flash Point | 97.8±0.0 °C |
| Exact Mass | 149.120453 |
| PSA | 26.02000 |
| LogP | 2.18 |
| Vapour Pressure | 0.1±0.4 mmHg at 25°C |
| Index of Refraction | 1.522 |
| InChIKey | WECUIGDEWBNQJJ-UHFFFAOYSA-N |
| SMILES | CC(N)CCc1ccccc1 |
| Storage condition | −20°C |
| Water Solubility | 8.5 g/L (20 ºC) |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Symbol |
GHS05 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H314 |
| Precautionary Statements | P280-P305 + P351 + P338-P310 |
| Personal Protective Equipment | Faceshields;full-face respirator (US);Gloves;Goggles;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter |
| Hazard Codes | C: Corrosive;Xi: Irritant;T: Toxic;F: Flammable; |
| Risk Phrases | R22;R34 |
| Safety Phrases | 26-36/37/39-45-28A-36/37 |
| RIDADR | UN 2735 8/PG 3 |
| WGK Germany | 2 |
| RTECS | UI3920000 |
| Packaging Group | III |
| HS Code | 29214980 |
| Precursor 10 | |
|---|---|
| DownStream 10 | |
| HS Code | 2921499090 |
|---|---|
| Summary | 2921499090 other aromatic monoamines and their derivatives; salts thereof VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:30.0% |
|
Quantification of Methylphenidate, Dexamphetamine, and Atomoxetine in Human Serum and Oral Fluid by HPLC With Fluorescence Detection.
Ther. Drug Monit. 38 , 98-107, (2016) For psychostimulants, a marked individual variability in the dose-response relationship and large differences in plasma concentrations after similar doses are known. Therefore, optimizing the efficacy... |
|
|
Identification and quantitation of an oxidative metabolite of labetalol in sheep: pharmacokinetic and metabolic implications.
Biol. Mass Spectrom. 21(11) , 534-40, (1992) A sensitive and selective assay has been developed for the identification and quantitation of 3-amino-1-phenyl butane (3-APB), a metabolite of labetalol, in biological fluids using electron impact gas... |
|
|
Disposition, metabolism, and pharmacodynamics of labetalol in adult sheep.
Drug Metab. Dispos. 21(2) , 284-92, (1993) Labetalol causes significant maternal and fetal metabolic effects in pregnant sheep (Yeleswaram et al., J. Pharmacol. Exp. Ther. 262, 683-691 (1992)). This study was undertaken to investigate the cont... |
| DL-1-methyl-3-phenyl-n-propylamine |
| α-Methyl phenethylamine |
| 1-Methyl-3-phenylpropylamine |
| Benzenepropanamine, α-methyl- |
| 1-phenyl-3-aminobutane |
| 4-phenylbutan-2-amine |
| 3-Amino-1-phenylbutane |
| EINECS 244-942-2 |
| (RS)-1-methyl-3-phenylpropylamine |
| (+/-)-1-methyl-3-phenylpropylamine |
| 4-Phenyl-2-aminobutane |
| 4-Phenyl-2-butanamine |
| UNII:326655W66Z |
| α-Methylbenzenepropanamine |
| MFCD00056185 |
| 4-Phenyl-2-butylamine |
| 2-Amino-4-phenylbutane |